Latest Drug delivery Stories

ALBANY, New York, May 21, 2013 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Biochip Products and Services Market (Microarrays, Reagents, Drug Discovery, Life Science Research, IVD Tests) - U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the market was valued at USD 2.4 billion in 2011 and is expected to grow at a CAGR of 10.1% from 2012 to 2018, to reach...

FARMINGTON, Conn., May 17, 2013 /PRNewswire-iReach/ -- The escalation of new biological drugs, including antibodies and recombinant proteins, is placing renewed emphasis on alternate delivery technologies. Alternate delivery technologies are on the rise as a number of factors are converging to create both risk and opportunity for pharmaceutical makers and their delivery device partners. These include new classes of drugs for previously refractory conditions, the growing trend toward...

CANTON, Mass., May 17, 2013 /PRNewswire/ -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that the Company's President and CEO, Michael Heffernan, will present the Company's corporate overview on Monday, May 20, 2013 at 1:30pm EDT at the UBS Global Health Care Conference. The conference will be held at the Sheraton New York Hotel in New York City. The Company's lead development program is Oxycodone DETERx(®), an abuse-deterrent,...

FARMINGTON, Conn., May 15, 2013 /PRNewswire-iReach/ -- World Pharma Congress is celebrating 12 years of preclinical research with its annual event covering the latest in drug targets, high-throughput screening, lead optimization, ADME and drug safety. Years of effectively covering the latest preclinical strategies and technologies that drive better predictions has culminated in priming this year's event to move further downstream into early formulations and drug delivery. (Photo:...

Aegis' Intravail® formulation of sumatriptan achieves therapeutic drug levels in approximately 2 to 3 minutes SAN DIEGO, May 14, 2013 /PRNewswire-iReach/ -- Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,440,631, its second patent providing fast acting formulations for triptans, a class of drugs that are effective in treating migraine headaches which include sumatriptan, zolmitriptan, naratriptan, rizatriptan, eletriptan, almotriptan and...

Columbia University Nanoscale technology used to drive a 'big' C60 through a 'small' H2O may help drug delivery Columbia Engineering researchers have developed a technique to isolate a single water molecule inside a buckyball, or C60, and to drive motion of the so-called "big" nonpolar ball through the encapsulated "small" polar H2O molecule, a controlling transport mechanism in a nanochannel under an external electric field. They expect this method will lead to an array of new...

Integral BioSystems will exhibit and offer its drug development expertise to attendees at the ARVO Annual Meeting at the Washington State Convention Center in Seattle, WA from May 5, 2013 through May 9, 2013 in Exhibitor Booth #517. Bedford, MA (PRWEB) May 05, 2013 The 2013 Meeting of the Association for Research and Vision in Ophthalmology, being held at the Washington State Convention Center in Seattle, WA combines a wide range of talks from commercial and academic figures in...

[316 Pages Report] Drug Delivery Technology Market Report categorizes the Global Market by Metered Dose Inhalers, Auto Injectors, Transdermal Patches, Drug Eluting Stentscand Infusion Pumps Forecasting - 2017. (PRWEB) May 02, 2013 The "Drug Delivery Technology Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017,"...

DUBLIN, April 30, 2013 /PRNewswire/ -- Research and Markets has announced the addition of the "Early Stage Drug Delivery Technologies: Profiles of Start-ups and Emerging Companies [http://www.researchandmarkets.com/research/fjrqvp/early_stage_drug ]" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The report focuses on start-ups and smaller companies that tend to be less well known, but are expected to gain momentum as...

ARAD, Israel, April 29, 2013 /PRNewswire/ -- Andain Inc [http://www.andaininc.com ]. (OTCBB: ANDN [http://finance.yahoo.com/q?s=ANDN ]) ("Andain" or the "Company"), a company engaged in commercializing novel technologies in biotech, medical and life sciences fields through its accelerating incubator program, announces today its innovative nano-particles drug delivery technology. Andain completed the development of innovative lipid-based drug delivery nano-particles...